PRISMA-DTA声明:诊断准确性系统评价与荟萃分析报告指南
PRISMA-DTA是PRISMA声明针对诊断准确性系统评价与荟萃分析的独立扩展版。该指南由24名多学科专家采用系统综述、3轮德尔菲法、共识会议、试点测试和迭代完善制定,最终形成27项清单,其中8项沿用、17项修改、2项新增、2项删除。
要点
- PRISMA-DTA清单共27项,用于规范诊断准确性系统评价与荟萃分析的报告。
- 制定过程包括系统综述(产出64条)、3轮德尔菲法、共识会议、试点测试和迭代完善。
- 最终清单较原始PRISMA:8项不变、17项修改、2项新增、2项删除。
核心结论
- 27项PRISMA-DTA清单为诊断准确性系统评价的报告提供具体指导,有助于透明报告、评估有效性与适用性、增强可重复性并提升结果实用性。
研究设计与样本
- 遵循EQUATOR Network标准,以原始PRISMA声明为框架,由24名多学科专家通过系统综述、3轮德尔菲法、共识会议、试点测试和迭代完善制定。
主要发现
- 系统综述产出64条,德尔菲过程对7项提议条目提供反馈(其中1项后来拆分为2项),共识别71项潜在相关条目。
- 德尔菲过程将71项缩减为60项,经共识会议后通过试点测试和迭代反馈生成27项PRISMA-DTA清单。
关键数值与推荐
- 最终清单27项中,8项原始PRISMA条目保持不变,17项修改,2项新增,2项删除。
临床怎么用
- 该清单可用于诊断准确性系统评价与荟萃分析的报告,以促进透明报告并辅助评估研究的有效性与适用性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Systematic reviews of diagnostic test accuracy synthesize data from primary diagnostic studies that have evaluated the accuracy of 1 or more index tests against a reference standard, provide estimates of test performance, allow comparisons of the accuracy of different tests, and facilitate the identification of sources of variability in test accuracy. OBJECTIVE: To develop the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagnostic test accuracy guideline as a stand-alone extension of the PRISMA statement. Modifications to the PRISMA statement reflect the specific requirements for reporting of systematic reviews and meta-analyses of diagnostic test accuracy studies and the abstracts for these reviews. DESIGN: Established standards from the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network were followed for the development of the guideline. The original PRISMA statement was used as a framework on which to modify and add items. A group of 24 multidisciplinary experts used a systematic review of articles on existing reporting guidelines and methods, a 3-round Delphi process, a consensus meeting, pilot testing, and iterative refinement to develop the PRISMA diagnostic test accuracy guideline. The final version of the PRISMA diagnostic test accuracy guideline checklist was approved by the group. FINDINGS: The systematic review (produced 64 items) and the Delphi process (provided feedback on 7 proposed items; 1 item was later split into 2 items) identified 71 potentially relevant items for consideration. The Delphi process reduced these to 60 items that were discussed at the consensus meeting. Following the meeting, pilot testing and iterative feedback were used to generate the 27-item PRISMA diagnostic test accuracy checklist. To reflect specific or optimal contemporary systematic review methods for diagnostic test accuracy, 8 of the 27 original PRISMA items were left unchanged, 17 were modified, 2 were added, and 2 were omitted. CONCLUSIONS AND RELEVANCE: The 27-item PRISMA diagnostic test accuracy checklist provides specific guidance for reporting of systematic reviews. The PRISMA diagnostic test accuracy guideline can facilitate the transparent reporting of reviews, and may assist in the evaluation of validity and applicability, enhance replicability of reviews, and make the results from systematic reviews of diagnostic test accuracy studies more useful.
引用
- McInnes MDF, Moher D, Thombs BD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018. PMID: 29362800. doi:10.1001/jama.2017.19163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。